DERM

Journey Medical Corp (DERM)

Healthcare • NASDAQ$5.07+1.40%

Key Fundamentals
Symbol
DERM
Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Price
$5.07
Daily Change
+1.40%
Market Cap
$138.65M
Trailing P/E
N/A
Forward P/E
-84.50
52W High
$9.56
52W Low
$4.31
Analyst Target
$13.50
Dividend Yield
N/A
Beta
1.03
About Journey Medical Corp

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and

Company website

Research DERM on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Terms · Privacy · ·

Loading...